Desjardins continues "BUY" recomendationJust announced this AM on BNN TV that Desjardins has continued it's "BUY" recomendation for TCM and has placed their one year target at $21.40....not sure if this is US dollars.
Looks like this will be a voltile ride for TCM but analysts continue with their upward value assessment based upon strong fundementals....
Perhaps today we will see some strong upward movement....